HeartSciences Inc. (HSCS) EBITDA
HeartSciences Inc. (HSCS) EBITDA
- 2026-07-31: Basis Reported; EBITDA (m); Operating income -$2.94M; Depreciation and amortization (m).
- 2026-01-31: Basis Reported; EBITDA (m); Operating income -$1.93M; Depreciation and amortization (m).
- 2025-10-31: Basis Reported; EBITDA (m); Operating income -$2.07M; Depreciation and amortization (m).
- 2025-07-31: Basis Reported; EBITDA (m); Operating income -$1.87M; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-07-31 | Reported | (m) | -$2.94M | (m) | $2.10K | (m) | (m) | -$1.32M | (m) | $906.63K | $2.03M | (m) |
|---|
| 2026-01-31 | Reported | (m) | -$1.93M | (m) | $0.00 | (m) | -$9.48K* | -$1.46M* | (m) | $638.58K | $1.29M | (m) |
|---|
| 2025-10-31 | Reported | (m) | -$2.07M | (m) | $2.42K | (m) | (m) | -$2.33M* | (m) | $727.03K | $1.35M | (m) |
|---|
| 2025-07-31 | Reported | (m) | -$1.87M | (m) | $1.90K | (m) | (m) | -$1.95M | (m) | $997.21K | $878.05K | (m) |
|---|
| 2025-01-31 | Reported | (m) | -$2.37M | (m) | $0.00 | (m) | $0.00* | -$1.62M* | (m) | $1.03M | $1.34M | (m) |
|---|
| 2024-10-31 | Reported | (m) | -$1.99M | (m) | (m) | (m) | (m) | -$2.18M* | (m) | $1.20M | $786.07K | (m) |
|---|
| 2024-07-31 | Reported | (m) | -$2.08M | (m) | (m) | (m) | (m) | -$2.02M | (m) | $1.22M | $850.74K | (m) |
|---|
| 2024-01-31 | Reported | (m) | -$1.53M | (m) | $14.70K | (m) | $8.79K* | -$2.10M* | (m) | $509.51K | $1.03M | (m) |
|---|
| 2023-10-31 | Reported | (m) | -$1.57M | (m) | $3.90K | (m) | $1.95K* | -$988.19K* | (m) | $757.30K | $815.02K | (m) |
|---|
| 2023-07-31 | Reported | (m) | -$1.33M | (m) | (m) | (m) | $4.91K | -$1.40M | (m) | $565.63K | $765.02K | (m) |
|---|
| 2023-01-31 | Reported | (m) | -$1.31M | (m) | $1.95K | (m) | $3.47K* | -$1.02M* | (m) | $643.26K | $667.24K | (m) |
|---|
| 2022-10-31 | Reported | (m) | -$1.77M | (m) | $0.00* | (m) | $0.00* | -$1.08M* | (m) | $848.98K | $925.93K | (m) |
|---|
| 2022-07-31 | Reported | (m) | -$1.43M | (m) | $3.20K | (m) | $7.25K | -$1.81M | (m) | $434.20K | $997.06K | (m) |
|---|
| 2022-01-31 | Reported | (m) | -$1.10M | (m) | $2.74K | (m) | $0.00* | -$966.28K* | (m) | $699.01K | $403.16K | (m) |
|---|
| 2021-10-31 | Reported | (m) | -$956.86K | (m) | $0.00* | (m) | (m) | -$768.05K* | (m) | $545.77K | $411.08K | (m) |
|---|
| 2021-07-31 | Reported | (m) | -$674.45K | (m) | $7.48K | (m) | (m) | -$717.49K | (m) | $401.11K | $275.06K | (m) |
|---|
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|
| 2026-04-30 | Reported | (m) | -$8.41M | (m) | $4.32K | (m) | $3.55K | -$7.43M | (m) | $2.84M | $5.58M | $0.00 |
|---|
| 2025-04-30 | Reported | (m) | -$8.35M | (m) | $4.35K | (m) | $3.16K | -$7.41M | (m) | $4.39M | $3.97M | $0.00 |
|---|
| 2024-04-30 | Reported | (m) | -$6.31M | (m) | $18.60K | (m) | $64.45K | -$6.07M | (m) | $2.88M | $3.44M | (m) |
|---|
| 2023-04-30 | Reported | (m) | -$6.11M | (m) | $5.15K | (m) | $18.31K | -$5.77M | (m) | $2.46M | $3.65M | (m) |
|---|
| 2022-04-30 | Reported | (m) | -$4.71M | (m) | $14.37K | (m) | $1.93K | -$3.64M | (m) | $3.00M | $1.71M | (m) |
|---|